EYPT
Price
$9.64
Change
-$0.73 (-7.04%)
Updated
Jun 27 closing price
Capitalization
664.03M
32 days until earnings call
FBIO
Price
$1.85
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
53.52M
Interact to see
Advertisement

EYPT vs FBIO

Header iconEYPT vs FBIO Comparison
Open Charts EYPT vs FBIOBanner chart's image
EyePoint Pharmaceuticals
Price$9.64
Change-$0.73 (-7.04%)
Volume$1.83M
Capitalization664.03M
Fortress Biotech
Price$1.85
Change-$0.00 (-0.00%)
Volume$228
Capitalization53.52M
EYPT vs FBIO Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. FBIO commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and FBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (EYPT: $9.64 vs. FBIO: $1.85)
Brand notoriety: EYPT and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 220% vs. FBIO: 0%
Market capitalization -- EYPT: $664.03M vs. FBIO: $53.52M
EYPT [@Biotechnology] is valued at $664.03M. FBIO’s [@Biotechnology] market capitalization is $53.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileFBIO’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • FBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than FBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while FBIO’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 4 bearish.
  • FBIO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both EYPT and FBIO are a good buy in the short-term.

Price Growth

EYPT (@Biotechnology) experienced а +14.49% price change this week, while FBIO (@Biotechnology) price change was +3.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($664M) has a higher market cap than FBIO($53.5M). EYPT YTD gains are higher at: 29.396 vs. FBIO (-10.123). FBIO has higher annual earnings (EBITDA): -89.64M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. FBIO (91.3M). EYPT has less debt than FBIO: EYPT (24.1M) vs FBIO (74.2M). FBIO (57.8M) and EYPT (56M) have equivalent revenues.
EYPTFBIOEYPT / FBIO
Capitalization664M53.5M1,241%
EBITDA-144.55M-89.64M161%
Gain YTD29.396-10.123-290%
P/E RatioN/AN/A-
Revenue56M57.8M97%
Total Cash318M91.3M348%
Total Debt24.1M74.2M32%
FUNDAMENTALS RATINGS
EYPT vs FBIO: Fundamental Ratings
EYPT
FBIO
OUTLOOK RATING
1..100
7970
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3558
P/E GROWTH RATING
1..100
17100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (33) in the Biotechnology industry is in the same range as EYPT (61) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's Profit vs Risk Rating (93) in the Pharmaceuticals Major industry is in the same range as FBIO (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to FBIO’s over the last 12 months.

EYPT's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as FBIO (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to FBIO’s over the last 12 months.

EYPT's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as FBIO (58) in the Biotechnology industry. This means that EYPT’s stock grew similarly to FBIO’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for FBIO (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTFBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FREVS16.250.25
+1.56%
First Real Estate Investment Trust of New Jersey Inc.
GLDAF2.45N/A
N/A
GLOBALDATA PLC
HKTTF1.48N/A
N/A
Hkt Trust and Hkt Ltd
TSDRF0.07N/A
N/A
Tsodilo Resources Limited
NSARO76.60-0.40
-0.52%
NSTAR Electric Co.

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-7.04%
OCUL - EYPT
64%
Loosely correlated
-2.54%
LYRA - EYPT
58%
Loosely correlated
-31.91%
BEAM - EYPT
57%
Loosely correlated
-1.98%
CRSP - EYPT
54%
Loosely correlated
+1.69%
ATHE - EYPT
54%
Loosely correlated
+0.34%
More

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with CRBP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-1.62%
CRBP - FBIO
38%
Loosely correlated
-7.73%
ABOS - FBIO
36%
Loosely correlated
-7.44%
EYPT - FBIO
35%
Loosely correlated
-7.04%
HOWL - FBIO
34%
Loosely correlated
-14.64%
RXRX - FBIO
33%
Loosely correlated
-6.85%
More